2-amino-5-phosphonovalerate has been researched along with veratrine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fink, K; Göthert, M; Schlicker, E | 1 |
| Henneberry, RC; Novelli, A | 1 |
2 other study(ies) available for 2-amino-5-phosphonovalerate and veratrine
| Article | Year |
|---|---|
Veratridine and other depolarizing agents counteract the inhibitory effect of Mg2+ ions on N-methyl-D-aspartate (NMDA)-induced noradrenaline release in vitro.
Topics: 2-Amino-5-phosphonovalerate; 4-Aminopyridine; Amifampridine; Animals; Aspartic Acid; Dibenzocycloheptenes; Dizocilpine Maleate; Electric Stimulation; Hydrogen; In Vitro Techniques; Magnesium; Male; N-Methylaspartate; Neuromuscular Depolarizing Agents; Norepinephrine; Potassium; Rats; Rats, Inbred Strains; Veratridine; Veratrine | 1990 |
Veratrine- and glutamate-stimulated cGMP production in cultured rat neurons is differentially inhibited by imipramine.
Topics: 2-Amino-5-phosphonovalerate; Animals; Cells, Cultured; Cerebellum; Cyclic GMP; Cytoplasmic Granules; Glutamates; Glutamic Acid; Imipramine; Neurons; Rats; Tetrodotoxin; Valine; Veratrine | 1985 |